Related Content
February 2, 2017 — Abbott announced U.S. Food and Drug Administration (FDA) approval for magnetic resonance (MR) ...
January 16, 2017 – In 2015, researchers and physicians at the Minneapolis Heart Institute Foundation (MHIF) were the ...
The biggest news from the 2016 Transcatheter Cardiovascular Therapeutics (TCT) meeting this past fall was the results of ...
January 9, 2017 — The U.S. Food and Drug Administration (FDA) issued a safety communication today concerning patient ...
January 5, 2017 — Abbott announced it completed the acquisition of St. Jude Medical Inc. The transaction provides Abbott ...
December 7, 2016 — Abbott has filed a complaint to terminate its proposed acquisition of Alere based on the substantial ...
Juan Granada, M.D., executive director and chief scientific officer of the Cardiovascular Research Foundation's Skirball ...
November 9, 2016 – Results from a randomized, multicenter trial failed to show non-inferiority of hybrid, ultra-thin ...
David Kandzari, M.D., director of interventional cardiology and chief scientific officer, Piedmont Heart Institute ...
October 31, 2016 — A major international study has found that drug-eluting stents, a less-invasive alternative to bypass ...